Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
- 26 November 2014
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 384 (9958), 1953-1997
- https://doi.org/10.1016/s0140-6736(14)61838-9
Abstract
No abstract availableThis publication has 130 references indexed in Scilit:
- Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisonsBMJ Open, 2013
- The relationship between minimum alcohol prices, outlet densities and alcohol-attributable deaths in British Columbia, 200209Addiction, 2013
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortJournal of Hepatology, 2012
- The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costsJournal of Public Health, 2011
- Priority actions for the non-communicable disease crisisThe Lancet, 2011
- Noninvasive assessment of liver fibrosisHepatology, 2010
- Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological modelThe Lancet, 2010
- The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisIntensive Care Medicine, 2010
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008